source
- Foghorn Therapeutics cuts 40% of staff after Lilly partnership ends over weak phase-1 dataFoghorn Therapeutics announced it will lay off 40% of its workforce after its long‑standing collaboration with Eli Lilly fell apart due to disappointing phase‑1 trial results. The partnership, lau…
- Study finds GLP-1 weight-loss drugs appear safe and effective for children with severe obesityA transplant surgeon and obesity‑medicine specialist at NYU Langone reports that his research on GLP-1 weight‑loss drugs in children yields reassuring results. He notes that many of his transplant…